Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-05-08Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2018-05-04A Clinical Study to Evaluate the Biological Effects of Intravenous Wild-type Reovirus (Reolysin®), With of Without GM-CSF, in Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2018-05-02This is an Open-label, Phase II Study of a Vaccine Comprising Melanoma Peptides and a Tetanus Helper Peptide, Administered in GM-CSF-in-adjuvant. Patients Will be Randomized to Receive One of Two Different Vaccine Regimens. Patients Will be Stratified by Stage of Disease (IIB vs. III vs. IV).
-
CLINICAL_TRIALS study record update · 2018-04-30A Phase l/ll, Open Label, Dose-escalation Study of Varlilumab (CDX-1127) in Combination With Atezolizumab (MPDL3280A, Anti-PD-L1) in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2018-04-27Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced (Unresectable or Metastatic) Melanoma: A Multicentric, Observational Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-04-23A Phase 2 Study of the Efficacy and Safety of Intratumoral CAVATAK™ (Coxsackievirus A21, CVA21) in Patients With Stage IIIc and Stage IV Malignant Melanoma to Extend Dosing for up to 48 Weeks Total (VLA-008 CALM Ext)
-
CLINICAL_TRIALS study record update · 2018-04-20A Phase II Study of High Dose Bolus IL2 in Patients With Inoperable Stage III or Stage IV Melanoma Who Have Failed Prior Anti-PD1 Immunotherapy: Efficacy and Biomarker Study
-
CLINICAL_TRIALS study record update · 2018-04-09The Effectiveness of Nivolumab (OPDIVO®) Monotherapy as First-Line Therapy in Adults With Advanced (Unresectable or Metastatic) Melanoma: An Early Retrospective, Observational Study in Germany
-
CLINICAL_TRIALS study record update · 2018-04-03Dose-seeking and Efficacy Study of the Combination of the BRAF Inhibitor Vemurafenib and High-dose Interferon Alfa-2b for Therapy of Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2018-03-23Feasibility and Safety of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma
-
CLINICAL_TRIALS study record update · 2018-03-23Feasibility of Lymphatic Mapping of Second Echelon Lymph Nodes With Methylene Blue
-
CLINICAL_TRIALS study record update · 2018-03-13A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-135 (JSC BIOCAD, Russia) in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2018-03-13Assessing the Safety and Efficacy of Multifunctional Skin-adhesive Nanoparticles for UV Protection in Humans
-
CLINICAL_TRIALS study record update · 2018-03-12Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes: A Phase 1b Study
-
CLINICAL_TRIALS study record update · 2018-03-06A Phase II Clinical Study on Efficacy of Palbociclib in Advanced Acral Melanoma With Cell Cycle Gene Aberrations
-
CLINICAL_TRIALS study record update · 2018-02-27Confocal Reflectance Microscopy of Shave-Biopsy Sites on Skin in Vivo
-
CLINICAL_TRIALS study record update · 2018-02-19A Multicenter, Randomized, Controlled, Phase III Trial Comparing High-Dose IFN-a2b With Temozolomide Plus Cisplatin as Systemic Adjuvant Therapy for Resected Mucosal Melanoma
-
CLINICAL_TRIALS study record update · 2018-02-19Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individual With Cancer
-
CLINICAL_TRIALS study record update · 2018-02-19Projecting Survival for Patients Treated With First-Line Ipilimumab-Nivolumab Combination Therapy Using a Prognostic Model and Cost Per Responder Model of Ipilimumab-Nivolumab Combination Therapy
-
CLINICAL_TRIALS study record update · 2018-02-14Pilot Study to Determine the Feasibility and Functionality of fPAM Imaging for the in Vivo Depth Measurement of Pigmented Lesions and Melanoma Depth
-
CLINICAL_TRIALS study record update · 2018-02-13Phase I/Phase II Open Label Study of the TLR3 Agonist Poly-ICLC as an Adjuvant for NY-ESO-1 Protein Vaccination With or Without Montanide ® ISA-51 VG in Patients With High Risk Melanoma in Complete Clinical Remission
-
CLINICAL_TRIALS study record update · 2018-02-06Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
-
CLINICAL_TRIALS study record update · 2018-01-31Phase III, Randomized, Double Blind Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients
-
CLINICAL_TRIALS study record update · 2018-01-26Expanded Access of MK-3475 in Metastatic Melanoma Patients With Limited to No Treatment Options
-
CLINICAL_TRIALS study record update · 2018-01-23Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC): A Phase II Clinical Study